NASDAQ (USD): Vir Biotechnology, Inc. (VIR)
Last Price
12.79
Today's Change
+0.31 (2.48%)
Day's Change
12.38 - 13.74
Trading Volume
3,272,164
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Stock Price
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
US Fed’s Waller Supports Further Cuts, Says Inflation Moving Lower
2
Tencent Makes Biggest Buyback Since 2006 After US Blacklist
3
Tesla Poised for US$1 Bil Windfall From EU’s Emissions Curbs
4
Micron to Spend US$7b Building Singapore Memory Chip Plant
5
US 30-year Mortgage Rate Just Shy of 7% Bridles Home Purchases
#
Stock
Score
MVST
Microvast Holdings, Inc.
DSW
750
VGLT
Vanguard Long-Term Treasury Index Fund
BABA
Alibaba Group Holding Limited
650
AGN
500
6
AEHR
Aehr Test Systems
7
OKLO
Oklo Inc.
8
DYAX
212916
9
CRNC
Cerence Inc.
10
TQQQ
ProShares UltraPro QQQ
Last
Change
Volume
CDT
0.12
+0.038
984,899,418
LICN
0.489
-1.631
183,350,854
VMAR
2.62
+1.10
158,219,165
RGTI
10.04
+0.005
120,672,327
QUBT
15.14
-10.54
120,604,778
LMDX
0.016
-0.018
120,553,903
NVDA
135.38
-4.73
118,616,409
DATS
6.67
+3.46
116,383,694
LILM
0.209
-0.334
112,784,715
MU
87.09
-16.81
87,924,604
CEG
299.14
+55.30
9,370,121
TPL
1,311.65
+35.71
56,329
CACI
431.39
+15.48
99,880
MELI
1,753.26
+14.26
185,480
ITCI
94.18
+11.62
2,387,878
EXEEL
90.10
+8.94
2,120
FTAI
177.46
+8.68
1,096,378
DXPE
92.39
+7.64
236,239
BOIL
64.55
+7.22
3,229,428
ESLT
281.19
+7.13
28,094
BRK-A
661,991.12
-15,933.90
1,516
1,774.05
-343.25
2,940,447
NVR
7,840.37
-165.58
7,898
BKNG
4,711.73
-160.69
115,966
MSTR
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
NOW
643.29
-87.83
5,025,012
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....